Numans Health Food Holdings Company Limited (NUMANS) announced that every motion tabled at its Annual General Meeting on 15 June 2026 was approved by poll with 100% of votes cast in favour. A total of 750.17 million shares—representing 75.02% of the company’s 1.00 billion shares in issue—were voted.

Key outcomes:

1. FY25 financial statements approved • Audited consolidated results and directors’ and auditor’s reports for the year ended 31 December 2025 received and adopted.

2. Cash distribution confirmed • Final dividend set at HK$0.025 per share, payable to shareholders on the register as of close of business 23 June 2026.

3. Board composition unchanged • Re-election of Executive Director Ms. Cui Juan and Non-executive Director Mr. Chan Hok Leung ratified. • Board authorised to determine directors’ remuneration.

4. Auditor reaffirmed • Forvis Mazars CPA Limited re-appointed; Board empowered to fix its fees.

5. Capital management flexibility maintained • 10% share buy-back mandate and 20% general issuance mandate granted. • Issue mandate extendable by the amount of shares repurchased under the buy-back mandate.

Tricor Investor Services Limited acted as scrutineer for vote-counting, and all directors attended the meeting in person or via electronic means.